1	Blockade	blockade	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	T-cell	t-cell	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	dithiocarbamates	dithiocarbamate	_	_	_	_	_	_	_
7	involves	involve	_	_	_	_	_	_	_
8	novel	novel	_	_	_	_	_	_	_
9	mechanisms	mechanism	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	inhibition	inhibition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	nuclear	nuclear	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Dithiocarbamates	dithiocarbamate	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	DTCs	DTC	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	recently	recently	_	_	_	_	_	_	_
7	been	be	_	_	_	_	_	_	_
8	reported	report	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	powerful	powerful	_	_	_	_	_	_	_
11	inhibitors	inhibitor	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
14	activation	activation	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	number	number	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	cell	cell	_	_	_	_	_	_	_
20	types	type	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Given	give	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	role	role	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	regulation	regulation	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	gene	gene	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	inflammatory	inflammatory	_	_	_	_	_	_	_
17	response	response	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
20	inhibitors	inhibitor	_	_	_	_	_	_	_
21	have	have	_	_	_	_	_	_	_
22	been	be	_	_	_	_	_	_	_
23	suggested	suggest	_	_	_	_	_	_	_
24	as	as	_	_	_	_	_	_	_
25	potential	potential	_	_	_	_	_	_	_
26	therapeutic	therapeutic	_	_	_	_	_	_	_
27	drugs	drug	_	_	_	_	_	_	_
28	for	for	_	_	_	_	_	_	_
29	inflammatory	inflammatory	_	_	_	_	_	_	_
30	diseases	disease	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	here	here	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	DTCs	DTC	_	_	_	_	_	_	_
6	inhibited	inhibit	_	_	_	_	_	_	_
7	both	both	_	_	_	_	_	_	_
8	interleukin	interleukin	_	_	_	_	_	_	_
9	2	2	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	synthesis	synthesis	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	membrane	membrane	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	antigens	antigen	_	_	_	_	_	_	_
19	which	which	_	_	_	_	_	_	_
20	are	be	_	_	_	_	_	_	_
21	induced	induce	_	_	_	_	_	_	_
22	during	during	_	_	_	_	_	_	_
23	T-cell	t-cell	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	inhibition	inhibition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	which	which	_	_	_	_	_	_	_
5	occurred	occur	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	parallel	parallel	_	_	_	_	_	_	_
9	activation	activation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	c-Jun	c-jun	_	_	_	_	_	_	_
12	transactivating	transactivating	_	_	_	_	_	_	_
13	functions	function	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	reflected	reflect	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	transfection	transfection	_	_	_	_	_	_	_
21	experiments	experiment	_	_	_	_	_	_	_
22	at	at	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	IL-2	il-2	_	_	_	_	_	_	_
25	promoter	promoter	_	_	_	_	_	_	_
26	level	level	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	involved	involve	_	_	_	_	_	_	_
30	not	not	_	_	_	_	_	_	_
31	only	only	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	inhibition	inhibition	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	NF-kappaB-driven	nf-kappab-driven	_	_	_	_	_	_	_
36	reporter	reporter	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	but	but	_	_	_	_	_	_	_
39	also	also	_	_	_	_	_	_	_
40	that	that	_	_	_	_	_	_	_
41	of	of	_	_	_	_	_	_	_
42	nuclear	nuclear	_	_	_	_	_	_	_
43	factor	factor	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	activated	activate	_	_	_	_	_	_	_
46	T	t	_	_	_	_	_	_	_
47	cells	cell	_	_	_	_	_	_	_
48	(	(	_	_	_	_	_	_	_
49	NFAT	NFAT	_	_	_	_	_	_	_
50	)	)	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Accordingly	accordingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	electrophoretic	electrophoretic	_	_	_	_	_	_	_
4	mobility	mobility	_	_	_	_	_	_	_
5	shift	shift	_	_	_	_	_	_	_
6	assays	assay	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	EMSAs	EMSA	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	indicated	indicate	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
13	DTC	DTC	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	PDTC	PDTC	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	prevented	prevent	_	_	_	_	_	_	_
18	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	NFAT	NFAT	_	_	_	_	_	_	_
22	DNA-binding	dna-binding	_	_	_	_	_	_	_
23	activity	activity	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	T	t	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	stimulated	stimulate	_	_	_	_	_	_	_
28	with	with	_	_	_	_	_	_	_
29	either	either	_	_	_	_	_	_	_
30	phorbol	phorbol	_	_	_	_	_	_	_
31	myristate	myristate	_	_	_	_	_	_	_
32	acetate	acetate	_	_	_	_	_	_	_
33	plus	plus	_	_	_	_	_	_	_
34	ionophore	ionophore	_	_	_	_	_	_	_
35	or	or	_	_	_	_	_	_	_
36	antibodies	antibody	_	_	_	_	_	_	_
37	against	against	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	CD3-T-cell	cd3-t-cell	_	_	_	_	_	_	_
40	receptor	receptor	_	_	_	_	_	_	_
41	complex	complex	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	simultaneously	simultaneously	_	_	_	_	_	_	_
44	activated	activate	_	_	_	_	_	_	_
45	the	the	_	_	_	_	_	_	_
46	binding	binding	_	_	_	_	_	_	_
47	of	of	_	_	_	_	_	_	_
48	AP-1	ap-1	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	PDTC	PDTC	_	_	_	_	_	_	_
4	differentially	differentially	_	_	_	_	_	_	_
5	targeted	target	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	NFATp	NFATp	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	NFATc	NFATc	_	_	_	_	_	_	_
10	family	family	_	_	_	_	_	_	_
11	members	member	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	inhibiting	inhibit	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	transactivation	transactivation	_	_	_	_	_	_	_
16	functions	function	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NFATp	NFATp	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	mRNA	mrna	_	_	_	_	_	_	_
21	induction	induction	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NFATc	NFATc	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Strikingly	strikingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	Western	western	_	_	_	_	_	_	_
4	blotting	blotting	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	immunocytochemical	immunocytochemical	_	_	_	_	_	_	_
7	experiments	experiment	_	_	_	_	_	_	_
8	indicated	indicate	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	PDTC	PDTC	_	_	_	_	_	_	_
11	promoted	promote	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	transient	transient	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	rapid	rapid	_	_	_	_	_	_	_
16	shuttling	shuttling	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NFATp	NFATp	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	NFATc	NFATc	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	leading	lead	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	their	their	_	_	_	_	_	_	_
25	accelerated	accelerate	_	_	_	_	_	_	_
26	export	export	_	_	_	_	_	_	_
27	from	from	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	nucleus	nucleus	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	activated	activate	_	_	_	_	_	_	_
32	T	t	_	_	_	_	_	_	_
33	cells	cell	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	propose	propose	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	an	an	_	_	_	_	_	_	_
8	NFAT	NFAT	_	_	_	_	_	_	_
9	kinase	kinase	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	PDTC	PDTC	_	_	_	_	_	_	_
12	could	could	_	_	_	_	_	_	_
13	be	be	_	_	_	_	_	_	_
14	responsible	responsible	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	rapid	rapid	_	_	_	_	_	_	_
18	shuttling	shuttling	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	NFAT	NFAT	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	therefore	therefore	_	_	_	_	_	_	_
24	transiently	transiently	_	_	_	_	_	_	_
25	converting	convert	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	sustained	sustained	_	_	_	_	_	_	_
28	transactivation	transactivation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	this	this	_	_	_	_	_	_	_
31	transcription	transcription	_	_	_	_	_	_	_
32	factor	factor	_	_	_	_	_	_	_
33	that	that	_	_	_	_	_	_	_
34	occurs	occur	_	_	_	_	_	_	_
35	during	during	_	_	_	_	_	_	_
36	lymphocyte	lymphocyte	_	_	_	_	_	_	_
37	activation	activation	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	and	and	_	_	_	_	_	_	_
40	show	show	_	_	_	_	_	_	_
41	that	that	_	_	_	_	_	_	_
42	c-Jun	c-jun	_	_	_	_	_	_	_
43	NH2-terminal	nh2-terminal	_	_	_	_	_	_	_
44	kinase	kinase	_	_	_	_	_	_	_
45	(	(	_	_	_	_	_	_	_
46	JNK	JNK	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	can	can	_	_	_	_	_	_	_
49	act	act	_	_	_	_	_	_	_
50	by	by	_	_	_	_	_	_	_
51	directly	directly	_	_	_	_	_	_	_
52	phosphorylating	phosphorylate	_	_	_	_	_	_	_
53	NFATp	NFATp	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	combined	combined	_	_	_	_	_	_	_
6	inhibitory	inhibitory	_	_	_	_	_	_	_
7	effects	effect	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	NFAT	NFAT	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	NF-KB	NF-KB	_	_	_	_	_	_	_
12	support	support	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	potential	potential	_	_	_	_	_	_	_
15	use	use	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	DTCs	dtc	_	_	_	_	_	_	_
18	as	as	_	_	_	_	_	_	_
19	immunosuppressants	immunosuppressant	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

